thymidine has been researched along with Chagas Disease in 7 studies
Chagas Disease: Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thymidine incorporation was somewhat inhibited when the diterpene was added at 12 h after removal of hydroxyurea, possibly on the transition S/G2." | 1.38 | The effect of the diterpene 5-epi-icetexone on the cell cycle of Trypanosoma cruzi. ( Barrera, P; Lozano, E; Nieto, M; Sartor, T; Sosa, MA; Tonn, C, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Seguel, V | 1 |
| Castro, L | 1 |
| Reigada, C | 1 |
| Cortes, L | 1 |
| Díaz, MV | 1 |
| Miranda, MR | 1 |
| Pereira, CA | 1 |
| Lapier, M | 1 |
| Campos-Estrada, C | 1 |
| Morello, A | 1 |
| Kemmerling, U | 1 |
| Maya, JD | 1 |
| López-Muñoz, R | 1 |
| Lozano, E | 1 |
| Barrera, P | 1 |
| Tonn, C | 1 |
| Nieto, M | 1 |
| Sartor, T | 1 |
| Sosa, MA | 1 |
| Ouaissi, A | 1 |
| Guevara-Espinoza, A | 1 |
| Chabé, F | 1 |
| Gomez-Corvera, R | 1 |
| Taibi, A | 1 |
| Buckner, FS | 1 |
| Wilson, AJ | 1 |
| Van Voorhis, WC | 1 |
| Fernández-Presas, AM | 1 |
| Zavala, JT | 1 |
| Fauser, IB | 1 |
| Merchant, MT | 1 |
| Guerrero, LR | 1 |
| Willms, K | 1 |
| O'Daly, JA | 1 |
| Beltz, LA | 1 |
| Kierszenbaum, F | 1 |
7 other studies available for thymidine and Chagas Disease
| Article | Year |
|---|---|
Pentamidine antagonizes the benznidazole's effect in vitro, and lacks of synergy in vivo: Implications about the polyamine transport as an anti-Trypanosoma cruzi target.
Topics: Animals; Chagas Disease; Chlorocebus aethiops; DNA, Protozoan; Dose-Response Relationship, Drug; Glu | 2016 |
The effect of the diterpene 5-epi-icetexone on the cell cycle of Trypanosoma cruzi.
Topics: Cell Cycle; Chagas Disease; Diterpenes; Humans; Hydroxyurea; Thymidine; Time Factors; Trypanosoma cr | 2012 |
A novel and basic mechanism of immunosuppression in Chagas' disease: Trypanosoma cruzi releases in vitro and in vivo a protein which induces T cell unresponsiveness through specific interaction with cysteine and glutathione.
Topics: Animals; Cells, Cultured; Chagas Disease; Cysteine; Glutathione; Humans; Immune Tolerance; Mice; Mic | 1995 |
Trypanosoma cruzi: use of herpes simplex virus-thymidine kinase as a negative selectable marker.
Topics: 3T3 Cells; Animals; Antiviral Agents; Blotting, Southern; Chagas Disease; Cloning, Molecular; Drug R | 1997 |
Ultrastructural damage of Trypanosoma cruzi epimastigotes exposed to decomplemented immune sera.
Topics: Animals; Antibodies, Protozoan; Chagas Disease; Complement Inactivator Proteins; Complement System P | 2001 |
A new liquid medium for Trypanosoma (Schizotrypanum) cruzi.
Topics: Animals; Autoradiography; Blood; Chagas Disease; Culture Media; Cytoplasmic Granules; DNA; Golgi App | 1975 |
Suppression of human lymphocyte responses by Trypanosoma cruzi.
Topics: Animals; Chagas Disease; Concanavalin A; Dose-Response Relationship, Immunologic; Immune Tolerance; | 1987 |